Inhibikase Therapeutics Inc (NAS:IKT)
$ 1.87 -0.020 (-1.06%) Market Cap: 246.91 Mil Enterprise Value: 159.28 Mil PE Ratio: 0 PB Ratio: 1.47 GF Score: 36/100